These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 21952072)

  • 1. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
    Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
    Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue.
    Qureshi-Baig K; Ullmann P; Rodriguez F; Frasquilho S; Nazarov PV; Haan S; Letellier E
    PLoS One; 2016; 11(1):e0146052. PubMed ID: 26745821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
    Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
    J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
    Greber B; Lehrach H; Adjaye J
    BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
    Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oct4 suppresses IR‑induced premature senescence in breast cancer cells through STAT3- and NF‑κB-mediated IL‑24 production.
    Kim JY; Kim JC; Lee JY; Park MJ
    Int J Oncol; 2018 Jul; 53(1):47-58. PubMed ID: 29749438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
    Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
    Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog.
    Schreiber C; Kuch V; Umansky V; Sleeman JP
    PLoS One; 2013; 8(2):e57465. PubMed ID: 23468991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breastmilk is a novel source of stem cells with multilineage differentiation potential.
    Hassiotou F; Beltran A; Chetwynd E; Stuebe AM; Twigger AJ; Metzger P; Trengove N; Lai CT; Filgueira L; Blancafort P; Hartmann PE
    Stem Cells; 2012 Oct; 30(10):2164-74. PubMed ID: 22865647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
    du Puy L; Lopes SM; Haagsman HP; Roelen BA
    Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
    Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
    PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary Gland.
    Hassiotou F; Hepworth AR; Beltran AS; Mathews MM; Stuebe AM; Hartmann PE; Filgueira L; Blancafort P
    Front Oncol; 2013; 3():79. PubMed ID: 23596564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data.
    Sharov AA; Masui S; Sharova LV; Piao Y; Aiba K; Matoba R; Xin L; Niwa H; Ko MS
    BMC Genomics; 2008 Jun; 9():269. PubMed ID: 18522731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
    Nishi M; Sakai Y; Akutsu H; Nagashima Y; Quinn G; Masui S; Kimura H; Perrem K; Umezawa A; Yamamoto N; Lee SW; Ryo A
    Oncogene; 2014 Jan; 33(5):643-52. PubMed ID: 23318426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen on the proportion of stem cells in the breast.
    Simões BM; Piva M; Iriondo O; Comaills V; López-Ruiz JA; Zabalza I; Mieza JA; Acinas O; Vivanco MD
    Breast Cancer Res Treat; 2011 Aug; 129(1):23-35. PubMed ID: 20859678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.